B-Cell Non-Hodgkin Lymphoma Clinical Trials
3 recruiting trials for B-Cell Non-Hodgkin Lymphoma. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT05702853
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
This is a single-center, nonrandomized, open-label dose-escalation study followed by dose-expansion of CD19- CD34t metabolically programmed CAR T-cell therapy in adult patients...
Sponsor: Medical University of South CarolinaEnrolling: 271 location
RECRUITINGPhase 1NCT04970901
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer...
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin, glofitamab, or mosunetuzumab,...
Sponsor: ADC Therapeutics S.A.Enrolling: 20020 locations
RECRUITINGPhase 2NCT06052826
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years...
This clinical trial compares the effectiveness of geriatric assessment (GA) guided interventions to accelerate functional recovery after chimeric antigen receptor T-cell (CAR-T)...
Sponsor: City of Hope Medical CenterEnrolling: 1641 location